COMPARISON OF PRIMARY AND SECONDARY FORMS OF MULTIPLE EVANESCENT WHITE DOT SYNDROME

  • Yasmine Serrar
    Service d’Ophtalmologie, Hôpital universitaire de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France;
  • Armelle Cahuzac
    Fondation Ophtalmologique Adolphe de Rothschild, Paris, France;
  • Pierre Gascon
    Department of Ophthalmology, Aix-Marseille University, Hopital Nord, Marseille, France;
  • Carole Langlois-Jacques
    Service de Biostatistiques, Hospices Civils de Lyon, Lyon, France;
  • Martine MAUGET-FAŸSSE
    Fondation Ophtalmologique Adolphe de Rothschild, Paris, France;
  • Benjamin Wolff
    Centre Ophtalmologique Maison Rouge, Strasbourg, France;
  • Pascal Sève
    Service de Médecine Interne, Hôpital universitaire de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France; and
  • Laurent Kodjikian
    Service d’Ophtalmologie, Hôpital universitaire de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France;
  • Thibaud Mathis
    Service d’Ophtalmologie, Hôpital universitaire de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France;

この論文をさがす

説明

<jats:sec> <jats:title>Purpose:</jats:title> <jats:p>The aim of this study was to compare primary versus secondary forms of multiple evanescent white dot syndrome (MEWDS) at T0 (baseline) and T1 (1–4 months after the onset of symptoms).</jats:p> </jats:sec> <jats:sec> <jats:title>Methods:</jats:title> <jats:p>A total of 101 eyes in 100 patients were included in a multicentric retrospective study.</jats:p> </jats:sec> <jats:sec> <jats:title>Results:</jats:title> <jats:p>Secondary MEWDS was defined as MEWDS associated with underlying chorioretinal inflammatory pathologies, mainly multifocal choroiditis and punctuate inner choroidopathy. Patients with secondary MEWDS were older (<jats:italic toggle="yes">P</jats:italic> = 0.011). The proportion of women (<jats:italic toggle="yes">P</jats:italic> = 0.8), spherical equivalent (<jats:italic toggle="yes">P</jats:italic> = 0.3), and best-corrected visual acuity at T0 (<jats:italic toggle="yes">P</jats:italic> = 0.2) were not significantly different between the two groups. The area of MEWDS lesions on late-phase indocyanine green angiography was significantly smaller in secondary MEWDS (<jats:italic toggle="yes">P</jats:italic> = 0.001) and less symmetrical with respect to both horizontal (<jats:italic toggle="yes">P</jats:italic> = 0.003) and vertical (<jats:italic toggle="yes">P</jats:italic> = 0.004) axis. At T0, neither the clinical (<jats:italic toggle="yes">P</jats:italic> = 0.5) nor the multimodal imaging (<jats:italic toggle="yes">P</jats:italic> = 0.2) inflammation scores were significantly different between the groups. At T1, the multimodal imaging inflammation score was higher in secondary MEWDS (<jats:italic toggle="yes">P</jats:italic> = 0.021).</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion:</jats:title> <jats:p>In secondary MEWDS, outer retinal lesions are less extensive and located close to preexisting chorioretinal lesions. Mild signs of intraocular inflammation on multimodal imaging are more frequent in secondary MEWDS during recovery. These findings suggest that chorioretinal inflammation may trigger secondary MEWDS.</jats:p> </jats:sec>

収録刊行物

  • Retina

    Retina 42 (12), 2368-2378, 2022-12

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ